1. Executive Summary
2. Market Snapshot
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. Business Landscape
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. Technological Outlook
5. Global Ophthalmic Drugs Market By Indication
5.1. Introduction
5.2. Dry Eye
5.3. Glaucoma
5.4. Infection/Inflammation/Allergies
5.5. Retinal Problems
5.6. Others
6. Global Ophthalmic Drugs Market By Product Type
6.1. Introduction
6.2. OTC Drug
6.3. Prescription Drug
7. Global Ophthalmic Drugs Market By Drug Form
7.1. Introduction
7.2. Liquid
7.3. Semi-solid
7.4. Solid
8. Global Ophthalmic Drugs Market By Drug Class
8.1. Introduction
8.2. Anti-Inflammatory
8.3. Anesthetic
8.4. Anti-Allergy
8.5. Others
9. Global Ophthalmic Drugs Market By Delivery Method
9.1. Introduction
9.2. Topical (Eye Drops, Ointments)
9.3. Intraocular
9.4. Intravitreal
9.5. Subconjunctival
9.6. Systemic
9.7. Oral
9.8. Intravenous
10. Global Ophthalmic Drugs Market By Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Retail Pharmacies
10.4. Online Pharmacies
11. Global Ophthalmic Drugs Market By Geography
11.1. Introduction
11.2. North America
11.2.2. By Product Type
11.2.3. By Drug Form
11.2.4. By Drug Class
11.2.5. By Delivery Method
11.2.6. By Distribution Channel
11.2.7. By Country
11.2.7.1. USA
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. South America
11.3.1. By Indication
11.3.2. By Product Type
11.3.3. By Drug Form
11.3.4. By Drug Class
11.3.5. By Delivery Method
11.3.6. By Distribution Channel
11.3.7. By Country
11.3.7.1. Brazil
11.3.7.2. Argentina
11.3.7.3. Others
11.4. Europe
11.4.1. By Indication
11.4.2. By Product Type
11.4.3. By Drug Form
11.4.4. By Drug Class
11.4.5. By Delivery Method
11.4.6. By Distribution Channel
11.4.7. By Country
11.4.7.1. Germany
11.4.7.2. France
11.4.7.3. United Kingdom
11.4.7.4. Spain
11.4.7.5. Others
11.5. Middle East and Africa
11.5.1. By Indication
11.5.2. By Product Type
11.5.3. By Drug Form
11.5.4. By Drug Class
11.5.5. By Delivery Method
11.5.6. By Distribution Channel
11.5.7. By Country
11.5.7.1. Saudi Arabia
11.5.7.2. UAE
11.5.7.3. Israel
11.5.7.4. Others
11.6. Asia Pacific
11.6.1. By Indication
11.6.2. By Product Type
11.6.3. By Drug Form
11.6.4. By Drug Class
11.6.5. By Delivery Method
11.6.6. By Distribution Channel
11.6.7. By Country
11.6.7.1. China
11.6.7.2. Japan
11.6.7.3. India
11.6.7.4. South Korea
11.6.7.5. Indonesia
11.6.7.6. Taiwan
11.6.7.7. Thailand
11.6.7.8. Others
12. Competitive Environment and Analysis
12.1. Major Players and Strategy Analysis
12.2. Market Share Analysis
12.3. Mergers, Acquisitions, Agreements, and Collaborations
12.4. Competitive Dashboard
13. Company Profiles
13.1. Sun Pharmaceutical Industries Ltd.
13.2. Bausch + Lomb Incorporated
13.3. Pfizer Inc.
13.4. Novartis AG
13.5. F. Hoffmann?La Roche Ltd.
13.6. AbbVie Inc.
13.7. Santen Pharmaceutical Co., Ltd.
13.8. Bayer AG
13.9. Teva Pharmaceutical Industries Ltd.
13.10. Merck & Co., Inc.
13.11. Otsuka Pharmaceutical Co., Ltd.
13.12. NicOx S.A.
14. Research Methodology
List of Figures
List of Tables